Needham & Company LLC reaffirmed a "buy" rating and issued a $17.00 price objective on shares of Bio...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Get Free Report) has earned a consensus rating of "Mod...
Here is how Acurx Pharmaceuticals, Inc. (ACXP) and BioCryst Pharmaceuticals (BCRX) have performed co...
The stock has a 36-month beta value of 1.10. Opinions on the stock are mixed, with 6 analysts rating...